Challenges of multimorbidities in the era of an aging population

Health Care Manager

Volumn 35, Issue 2, 2016, Pages 134-143

  Jung, Minsoo ^a  

^a Dongduk Women's University   (South Korea)

Author keywords

aging population; multimorbidities; noncommunicable diseases

Indexed keywords

AGING; CHRONIC DISEASE; COMORBIDITY; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; REIMBURSEMENT; TRENDS;

AGING; CHRONIC DISEASE; COMORBIDITY; DELIVERY OF HEALTH CARE; HUMANS; REIMBURSEMENT MECHANISMS;

EID: 84966552161     PISSN: 15255794     EISSN: 1550512X     Source Type: Journal    
DOI: 10.1097/HCM.0000000000000106     Document Type: Article

References (89)

1. World Health Organization. Global Status Report on Noncommunicable Diseases. WHO, 2010. https://.www.who.int/nmh/publications/ncd-report-full-en.pdf. Accessed March. 13, 2015.
2. United Nations General Assembly. Scope, Modalities, Format, and Organization of the High-level Meeting of the General Assembly on the Prevention, and Control of Non-communicable Diseases, 65th Session, Agenda item. 115, Resolution 65/238, Dated April 7, 2011.https://www.un.org/en/ga/president/65/issues/.A-RES-65-238.pdf. Accessed March. 13, 2015.
3. 3, Anderson GF. Chronic Care: Making the Case for Ongoing Care. Princeton, NJ: Robert Wood Johnson Foundation; 2010.
4. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002; 162(20): 2269-2276.
5. van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of rand omized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007; 297(11): 1233-1240.
6. PimentelM, Lembo A, Chey WD, et al; TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011; 364(1): 22-32.
7. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines, and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005; 294(6): 716-724.
8. Smith S, Newhouse JP, Freeland MS. Income, insurance, and technology: why does health spending outpace economic growth?. Health Aff (Millwood). 2009; 28(5): 1276-1284.
9. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity, and smoking on U.S. life expectancy. N Engl J Med. 2009; 361(23): 2252-2260.
10. Costa-Font J, Wittenberg R, Patxot C, et al. Projecting long-Term care expenditure in four European Union member states: the influence of demographic scenarios. Soc Ind Res. 2008; 86(2): 303-321.
11. Organization for Economic Cooperation, and Development (OECD). OECD Health Data 2010. Paris, France: OECD Publishing; 2010.
12. Bloom DE, Canning D. Global demographic change: dimensions, and economic significance. Pop Dev Rev. 2008; 34: 17-51.
13. Stauner G. The future of social security systems, and demographic change. Eur View. 2008; 7: 203-208.
14. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009; 374(9696): 1196-1208.
15. Rajoy M. Demographic trends in Southern Europe: rethinking thewelfare state. Eur View. 2008; 7: 195-202.
16. Stabile M, Greenblatt J. Providing Pharmacare for an Aging Population: Is Prefunding the Solution?. IRPP Study No. 2. Montréal, Canada: Institute for Research on Public Policy; 2010.
17. Mann T. Modern demographic trends in the EU. Eur View. 2008; 7: 187-194.
18. Santerre RE, Neun SP. Health Economics: Theories, Insights, and Industries Studies. 5th international edition. New York: Cengage Learning; 2010.
19. Folland S, Goodman AC, Stano M. ComparativeHealth Care Systems. 6th ed. New York: Prentice Hall; 2009.
20. Organization for Economic Cooperation, and Development (OECD). Ageing, and Employment Policies: Live Longer, Work Longer. Paris, France. OECD Publishing; 2006.
21. Palier B A Long Goodbye to Bismarck?: The Politics ofWelfare Reform in Continental Europe. Amsterdam: Amsterdam University Press; 2010.
22. Centers for Disease Control, and Prevention (CDC). Trends in aging-United States, and worldwide. MMWR Morb Mortal Wkly Rep. 2003; 52(6): 101-104, 106.
23. Bamford SM, Walker T. Women, and dementia-not forgotten. Maturitas. 2012; 73(2): 121-126.
24. Bamford C, Lamont S, Eccles M, Robinson L, May C, Bond J. Disclosing a diagnosis of dementia: a systematic review. Int J Geriatr Psychiatry. 2004; 19(2): 151-169.
25. Werner P, Karnieli-Miller O, Eidelman S. Current knowledge, and future directions about the disclosure of dementia: a systematic review of the first decade of the 21st century. Alzheimers Dement. 2013; 9(2): e74-e88.
26. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Diseases. Technical Report No. 916. Geneva: WHO; 2003.
27. Semuels A. Jobs increase but wages have fallen. LA Times May. 31, 2011. https://www.tnj.com/career/.jobsincrease-wages-have-fallen. Accessed March. 20, 2015.
28. Kelly G. Why the squeezed middle is here to stay. The Guardian. May. 22, 2011. http://www.the guardian.com/politics/2011/may/22/squeezed middle-here-To-stay. Accessed March. 25, 2015.
29. Parker MG, Thorslund M. Health trends in the elderly population: getting better, and getting worse. Gerontologist. 2007; 47(2): 150-158.
30. Howker E, Malik S. Jilted Generation: How Britain Has Bankrupted Its Youth. London: Icon Books Ltd; 2010.
31. Smith H. Greek government faces revolt over second wave of austerity measures. The Guardian. June 6, 2011. http://www.theguardian.com/business/2011/.jun/06/greece-faces-revolt-more-Austerity-measures. Accessed March. 25, 2015
32. Chappell NL, Hollander MJ. An evidence-based policy prescription for an aging population. Health Pap. 2011; 11(1): 8-18.
33. Lloyd-Jones DM, Leip EP, Larson MG, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006; 113(6): 791-798.
34. Emery P. Treatment of rheumatoid arthritis. BMJ. 2006; 332(7534): 152-155.
35. Emery P, Breedveld FC, Hall S, et al. Comparison of methotrexate monotherapy with a combination of methotrexate, and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a rand omised, double-blind, parallel treatment trial. Lancet. 2008; 372(9636): 375-382.
36. Docteur E, Oxley H. Healthcare Systems: Lessons FromReform. Paris, France: OECD Publishing; 2003.
37. Caulfield T, Zarzeczny A. Defining medical necessity in an age of personalised medicine: a view from Canada. Bioessays. 2014; 36(9): 813-817.
38. Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people, and implications for health policy, and practice. Lancet. 2015; 385(9967): 549-562.
39. Gusmano MK, Allin S. Framing the issue of ageing, and health care spending in Canada, the United Kingdom, and the United States. Health Econ Policy Law. 2014; 9(3): 313-328.
40. Imai H, Fujii Y, Fukuda Y, Nakao H, Yahata Y. Healthrelated quality of life, and beneficiaries of long-Term care insurance in Japan. Health Policy. 2008; 85(3): 349-355.
41. Tsutsui T, Muramatsu N. Japans universal long-Term care system reform of 2005: containing costs, Andrealizing a vision. J Am Geriatr Soc. 2007; 55(9): 1458-1463.
42. Ohwaki K, Hashimoto H, Sato M, Tamiya N, Yano E. Predictors of continuity in home care for the elderly under public long-Termcare insurance in Japan. Aging Clin Exp Res. 2009; 21(4-5): 323-328.
43. Wu IC, Chang HY, Hsu CC, et al. Association between dietary fiber intake, and physical performance in older adults: a nationwide study in Taiwan. PLoS One. 2013; 8(11): e80209.
44. Khunti K, Walker N, Sattar N, Davies M. Unanswered questions over NHS health checks. BMJ. 2010; 342: 6312.
45. Shah SM, Carey IM, Harris T, DeWilde S, Cook DG. Mortality in older care home residents in England, and Wales. Age Ageing. 2013; 42(2): 209-215.
46. Bradley MC, Motterlini N, Padmanabhan S, et al. Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatr. 2014; 14: 72.
47. Fleming A, Browne J, Byrne S. The effect of interventions to reduce potentially inappropriate antibiotic prescribing in long-Term care facilities: a systematic review of rand omised controlled trials. Drugs Aging. 2013; 30(6): 401-408.
48. Gusmano MK, Michel JP. Life course vaccination, and healthy aging. Aging Clin Exp Res. 2009; 21(3): 258-263.
49. Gillespie M. Relapse in long-Term conditions: learning from mental health methods. Br J Nurs. 2010; 19(19): 1236-1242.
50. Fendrich K, van den Berg N, Siewert U, Hoffmann W. Demographic change: demand s on the health care system, and solutions using the example ofMecklenburg-Western Pomerania. Bundesgesundheitsbl Gesundheitsforsch Gesundheitssch. 2010; 53(5): 479-485.
51. Boulos MN, Wheeler S, Tavares C, Jones R. How smartphones are changing the face of mobile, and participatory healthcare: an overview, with example from eCAALYX. Biomed Eng Online. 2011; 10: 24.
52. Rocha A, Martins A, Freire Junior JC, et al. Innovations in health care services: the CAALYX system. Int J Med Inform. 2013; 82(11): e307-e320.
53. Ampe S, Sevenants A, Coppens E, et al. Study protocol for we DECide: implementation of advance care planning for nursing home residents with dementia. J Adv Nurs. 2015; 71(5): 1156-1168.
54. European Commission. Turning European Into a True Innovation Union. Memo 10/473. October 6, 2010. http://europa.eu/rapid/press-release-MEMO-10-473-en.htm. Accessed March. 29, 2015.
55. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understand ing health, and health services. Ann Fam Med. 2009; 7(4): 357-363.
56. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression, and chronic illnesses. N Engl J Med. 2010; 363(27): 2611-2620.
57. Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases: a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011; 66(3): 301-311.
58. Salisbury C, Johnson L, Purdy S, Valderas JM, Montgomery AA. Epidemiology, and impact of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract. 2011; 61(582): e12-e21.
59. Gunn JM, Ayton DR, Densley K, et al. The association between chronic illness, multimorbidity, and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(2): 175-184.
60. Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence, and trend over the last 20 years. Eur J Gen Pract. 2008; 14(suppl 1): 28-32.
61. McKee M, Nolte E. Responding to the challenge of chronic diseases: ideas from Europe. Clin Med. 2004; 4(4): 336-342.
62. Nolte E, McKee M. Measuring the health of nations: analysis of mortality amenable to health care. BMJ. 2003b; 327(7424): 1129.
63. Nolte E, McKee M. Population health in Europe: how much is attributable to health care?. World Hosp Health Serv. 2004c; 40(3): 12-14, 40, 42.
64. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Bos GA. Causes, and consequences of comorbidity: a review. J Clin Epidemiol. 2001; 54(7): 661-674.
65. Bayliss EA, Edwards AE, Steiner JF, Main DS. Processes of care desired by elderly patients with multimorbidities. Fam Pract. 2008; 25(4): 287-293.
66. Fortin M, Bravo G, Hudon C, Lapointe L, Dubois MF, Almirall J. Psychological distress, and multimorbidity in primary care. Ann Fam Med. 2006; 4(5): 417-422.
67. Kadam UT, Croft PR; North Staffordshire GP Consortium Group. Clinical multimorbidity, and physical function in older adults: a record, and health status linkage study in general practice. Fam Pract. 2007; 24(5): 412-419.
68. May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009; 339: 2803.
69. Starfield B, Shi L, Macinko J. Contribution of primary care to health systems, and health. Milbank Q. 2005; 83(3): 457-502.
70. OBrien R, Wyke S, Guthrie B, Watt G, Mercer S. An endless struggle: a qualitative study of general practitioners. and practice nurses experiences of managing multimorbidity in socio-economically deprived areas of Scotland . Chronic Illn. 2011; 7(1): 45-59.
71. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: theres got to be a happy medium. JAMA. 2010; 304(14): 1592-1601.
72. Aronson JK. Polypharmacy, appropriate, and inappropriate. Br J Gen Pract. 2006; 56(528): 484-485.
73. Gallagher P, OMahony D. STOPP (Screening Tool of Older Persons potentially inappropriate Prescriptions): application to acutely ill elderly patients, and comparison with Beers criteria. Age Ageing. 2008; 37(6): 673-679.
74. Steinman MA, LandefeldCS, RosenthalGE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy, and prescribing quality in older people. J Am Geriatr Soc. 2006; 54(10): 1516-1523.
75. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy-An individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010; 10: 16.
76. Boyd CM, Weiss CO, Halter J, Han KC, Ershler WB, Fried LP. Framework for evaluating disease severity measures in older adults with comorbidity. J Gerontol A Biol Sci Med Sci. 2007; 62(3): 286-295.
77. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011; 342: 3514.
78. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM Study Group. Frequency of, and risk factors for preventable medication-related hospital admissions in the Netherland s. Arch Intern Med. 2008; 168(17): 1890-1896.
79. Gunn JM, Palmer VJ, Naccarella L, et al. The promise, and pitfalls of generalism in achieving the Alma-Ata vision of health for all. Med J Aust. 2008; 189(2): 110-112.
80. Guthrie B, Saultz JW, Freeman GK, Haggerty JL. Continuity of care matters. BMJ. 2008; 337: 867.
81. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003; 327(7425): 1219-1221.
82. Nutting PA, Crabtree BF, Miller WL, Stewart EE, Stange KC, Jaén CR. Journey to the patient-centered medical home: a qualitative analysis of the experiences of practices in the National Demonstration Project. Ann Fam Med. 2010; 8(suppl 1): S45-S56.
83. Crabtree BF, Nutting PA, Miller WL, Stange KC, Stewart EE, Jaén CR. Summary of the National Demonstration Project, and recommendations for the patient-centered medical home. Ann Fam Med. 2010; 8(suppl 1): S80-S90.
84. Beswick AD, Rees K, Dieppe P, et al. Complex interventions to improve physical function, and maintain independent living in elderly people: a systematic review, and meta-Analysis. Lancet. 2008; 371(9614): 725-735.
85. Gravelle H, Dusheiko M, Sheaff R, et al. Impact of case management (Evercare) on frail elderly patients: controlled before, and after analysis of quantitative outcome data. BMJ. 2007; 334(7583): 31.
86. Battersby M, Von Korff M, Schaefer J, et al. Twelve evidence-based principles for implementing selfmanagement support in primary care. J Comm J Qual Patient Saf. 2010; 36(12): 561-570.
87. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002; 288(19): 2469-2475.
88. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003; 26(1): 1-7.
89. Rijken M, van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases: effects of disease pairs on physical, and mental functioning. Qual Life Res. 2005; 14(1): 45-55.